Search results: Sage Journals

Open accessResearch articleFirst published February, 2026

Adverse drug reactions associated with doxorubicin and epirubicin: A descriptive analysis from VigiBase

Deborah A. Matesun, Kofi Boamah Mensah, Peter Yamoah [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published January, 2018

Safety profile of gadoxetate disodium in elderly patients (≥65 years)

Jan Endrikat, Carsten Schwenke, Kai Vogtlaender [...]

Acta Radiologica

Open accessResearch articleFirst published 2024

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Dongxuan Li, Chunmeng Qin, Hongli Wang [...]

Therapeutic Advances in Drug Safety

Restricted accessResearch articleFirst published June, 2022

Molecular Characterization of the pol Gene of Vertically Transmitted HIV-1 Strains in Children with Virological Failure

Ramesh Karunaianantham, Manohar Nesa Kumar, Bindu Gopalan [...]

AIDS Research and Human Retroviruses

Restricted accessResearch articleFirst published April, 2026

Comparative Analysis of Adverse Drug Reactions Between Oritavancin Diphosphate and Oritavancin-HPβCD Using FAERS Data

Eleonora Castellana, Maria Rachele Chiappetta

Hospital Pharmacy

Restricted accessResearch articleFirst published October, 2025

Pharmacovigilance and Stevens-Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN): 55 Years of Retrospective Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Eleonora Castellana, Patricia Madalina Budau, Maria Rachele Chiappetta

Hospital Pharmacy

Open accessResearch articleFirst published 2023

Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan

Ichiro Nakashima, Jin Nakahara, Hiroaki Yokote [...]

Therapeutic Advances in Neurological Disorders

Restricted accessResearch articleFirst published February, 2026

Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments

Jessie Signorelli, Christopher Bell, Stephanie Monaco

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published September, 2023

Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan

Hui-Lin Liu, Cheng-Hao Chuang, Chin-Ling Chen [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published January, 2011

Myoclonus After Dextromethorphan Administration in Peritoneal Dialysis

Akio Tanaka, Tadashi Nagamatsu, Makoto Yamaguchi [...]

Annals of Pharmacotherapy

Open accessResearch articleFirst published February, 2026

Adverse drug reactions associated with doxorubicin and epirubicin: A descriptive analysis from VigiBase

Deborah A. Matesun, Kofi Boamah Mensah, Peter Yamoah [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published January, 2018

Safety profile of gadoxetate disodium in elderly patients (≥65 years)

Jan Endrikat, Carsten Schwenke, Kai Vogtlaender [...]

Acta Radiologica

Open accessResearch articleFirst published 2024

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Dongxuan Li, Chunmeng Qin, Hongli Wang [...]

Therapeutic Advances in Drug Safety

Restricted accessResearch articleFirst published June, 2022

Molecular Characterization of the pol Gene of Vertically Transmitted HIV-1 Strains in Children with Virological Failure

Ramesh Karunaianantham, Manohar Nesa Kumar, Bindu Gopalan [...]

AIDS Research and Human Retroviruses

Restricted accessResearch articleFirst published April, 2026

Comparative Analysis of Adverse Drug Reactions Between Oritavancin Diphosphate and Oritavancin-HPβCD Using FAERS Data

Eleonora Castellana, Maria Rachele Chiappetta

Hospital Pharmacy

Restricted accessResearch articleFirst published October, 2025

Pharmacovigilance and Stevens-Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN): 55 Years of Retrospective Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Eleonora Castellana, Patricia Madalina Budau, Maria Rachele Chiappetta

Hospital Pharmacy

Open accessResearch articleFirst published 2023

Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan

Ichiro Nakashima, Jin Nakahara, Hiroaki Yokote [...]

Therapeutic Advances in Neurological Disorders

Restricted accessResearch articleFirst published February, 2026

Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments

Jessie Signorelli, Christopher Bell, Stephanie Monaco

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published September, 2023

Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan

Hui-Lin Liu, Cheng-Hao Chuang, Chin-Ling Chen [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published January, 2011

Myoclonus After Dextromethorphan Administration in Peritoneal Dialysis

Akio Tanaka, Tadashi Nagamatsu, Makoto Yamaguchi [...]

Annals of Pharmacotherapy